![](/img/cover-not-exists.png)
Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes
Borthakur, Gautam, Huang, Xuelin, Kantarjian, Hagop, Faderl, Stefan, Ravandi, Farhad, Ferrajoli, Alessandra, Torma, Ritva, Morris, Gail, Berry, Donald, Issa, Jean-PierreVolume:
51
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428190903318329
Date:
January, 2010
File:
PDF, 162 KB
english, 2010